![](/accounts/asam/images/printLogo.png)
RECENTLY ADDED
-
Contains 4 Component(s)
Live events in April
Live events in April
-
Register
- Non-Member - Free!
- Regular Member - Free!
- Retired - Free!
- Early Career Physician - Free!
- Resident - Free!
- Student - Free!
- Associate - Free!
- ASAM Staff - Free!
- International Member - Free!
- Emeritus Member - Free!
- Provisional Member - Free!
- Fellow Member - Free!
- Honorary Member - Free!
- CRT Member - Free!
- More Information
-
Register
-
Contains 5 Component(s), Includes Credits
Component Credit Type State/Medical Type Available Credits Earned Credits Credit Medical Physician - Online 2.50 0.00 Credit Medical Non-Physician - Online 2.50 0.00 Review safe prescribing habits and examine the difference between extended release/long acting medications to help ensure patient safety and effective pain management.
The misuse of extended-release and long-acting (ER/LA) opioids is a major public health problem. Centers for Disease Control and Prevention reported the following:
- From 2000 to 2015 more than half a million people died from drug overdoses.
- 91 Americans die every day from an opioid overdose.
The CO*RE/ASAM Opioid Prescribing: Safe Practice, Changing Lives course addresses the opioid public health crisis. This comprehensive course was developed by renowned experts from Collaborative for REMS Education (CO*RE) and incorporates all six units outlined in FDA blueprint for safe opioid prescribing. The updated course also provides necessary context for safe opioid prescribing by discussing biopsychosocial aspects of pain, the newest clinical guidelines on the treatment of chronic pain, and state policies about prescribing opioids.
Learners will be able to:
- Accurately assess patients with pain for consideration of an opioid trial
- Establish realistic goals for pain management and restoration of function
- Initiate opioid treatment (IR and ER/LA) safely and judiciously, maximizing efficacy while minimizing risks
- Monitor and re-evaluate treatment continuously; discontinue safely when appropriate
- Counsel patients and caregivers about use, misuse, abuse, diversion, and overdose
- Educate patients about safe storage and disposal of opioids
- Demonstrate working knowledge and ability to access general and specific information about opioids, especially those used in your practice.
Edwin A. Salsitz
MD, DFASAM
Dr. Edwin A. Salsitz has been an attending physician at Mount Sinai Beth Israel, Department of Psychiatry and Behavioral Sciences, since 1983, and is an Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai. He is the principal investigator of the Methadone Medical Maintenance (office-based methadone maintenance) research project. Dr. Salsitz is certified by the American Board of Addiction Medicine (ABAM), as well as by the Board of Internal Medicine and Pulmonary Disease. He lectures frequently and has been published on a variety of addiction medicine topics.
Dr. Salsitz is a course director for ASAM sponsored buprenorphine trainings, and is a mentor in the PCSS-MAT and PCSS-O mentoring programs. He has co-chaired the ASAM Review Course, the ASAM Common Threads Course, the ASAM State of the Art Course and is a reviewer for the Journal of Addiction Medicine. Currently Dr. Salsitz is the chair of the ASAM REMS ER/LA Opioids committee. Dr. Salsitz is a member of the ASAM CME committee and Chair of the New York Society of Addiction Medicine CME and Education committee. He is the recipient of the 2014 ASAM Annual AwardDr. Salsitz is a member of the Medical Advisory Panel, for the New York State Office of Alcohol and Substance Abuse Services.
Kirk Moberg
MD, PhD, FASAM
Dr. Moberg has served as medical director of three addiction recovery centers, currently the Illinois Institute for Addiction Recovery in Peoria, IL. He also serves as Clinical Professor in the departments of Internal Medicine and Psychiatry & Behavioral Medicine at UICOM. He holds extensive accomplishments in managing healthcare quality and outcomes; implementing performance improvement and project management methods; managing hospital, medical group, and managed care operations. He is certified by the American Board of Internal Medicine, the American Board of Addiction Medicine and the Certifying Commission for Medical Management.
He is a member of the board of the Illinois Society of Addiction Medicine and the National Rural Association for Alcohol and Drug Abuse, Inc. Dr. Moberg also serves on the Advisory Committee of the Illinois Professional Health Program.
CME Information and Disclosure Listing
The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Society of Addiction Medicine designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This course has been designated as an approved CME Activity by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Maintenance of Certification (MOC) Program can apply a maximum of 2.5 AMA PRA Category 1 Credits™ to the CME requirement for Part II: Lifelong Learning and Self-Assessment.
In accordance with the disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all educational activities. These policies include resolving all conflicts of interest between the CME Committee, Planning Committee and faculty, and commercial interests that might otherwise compromise the goal and educational integrity of this activity. All CME Committee, Planning Committee and faculty participating in the activity have disclosed all relevant financial relationships with commercial interests. The CME Committee has reviewed these disclosures and determined that the planning committee and faculty relationships are not inappropriate in the content of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.
ASAM CME Committee
Name
Nature of Relevant Financial Relationship
Commercial Interest
What was received?
For what role?
Adam J. Gordon, MD, MPH, FACP, DFASAM
None
Catherine Friedman, MD
None
Noel Ilogu, MD, MRCP None Herbert Malinoff, MD, FACP, DFASAM
None
Edwin A. Salsitz, MD, DFASAM
None
John Tanner, DO, DFASAM
Reckitt
Astra Zeneca
Pfizer
Alkermes
Honorarium
Honorarium
Honorarium
Honorarium
Speaker
Speaker
Speaker
Speaker
Program Planning Committee
Name
Nature of Relevant Financial Relationship
Commercial Interest
What was received?
For what role?
Herbert Malinoff, MD, FACP, DFASAM
None
Yngvild Olsen, MD, MPH
None
Theodore Parran, MD
None
Edwin Salsitz, MD, DFASAM
None
R. Corey Waller, MD, MS, FACEP, DFASAM
None
Course FacultyName
Nature of Relevant Financial Relationship
Commercial Interest
What was received?
For what role?
Edwin Salsitz, MD, DFASAM
None
Kirk Moberg, MD, PhD, FASAM None ASAM CME Committee Reviewers
Name
Nature of Relevant Financial Relationship
Commercial Interest
What was received?
For what role?
Jacob Bobrowski, MD, FAAFP
None
Anthony H. Dekker, DO, DFASAM
None
Acknowledgement
Presented by ASAM, a member of the Collaborative on REMS Education (CO*RE), 10 interdisciplinary organizations working together to improve pain management and prevent adverse outcomes.
RPC Commercial Support Disclosure Statement
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies. Please see this link for a listing of the member companies. This activity is intended to be fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration.
This course is not intended to advocate for the use of ER/LA Opioids, but to ensure proper education about safe prescribing practices should a medical provider determine that ER/LA Opioids are the best course of treatment.
-
Register
- Regular Member - Free!
- Retired - Free!
- Early Career Physician - Free!
- Resident - Free!
- Student - Free!
- Associate - Free!
- ASAM Staff - Free!
- Non-Member - Free!
- International Member - Free!
- Emeritus Member - Free!
- Provisional Member - Free!
- Fellow Member - Free!
- Honorary Member - Free!
- CRT Member - Free!
- More Information
-
Contains 4 Component(s), Includes Credits
Component Credit Type State/Medical Type Available Credits Earned Credits CME Certificate Medical Physician - Online 1.00 0.00 CME Certificate Medical Non-physician - Online 1.00 0.00 This webinar helps build knowledge of The ASAM Appropriate Use of Drug Testing in Clinical Addiction Medicine document, which guides provider decisions about drug testing, as no universal standard exists today.
This webinar helps build knowledge of The ASAM Appropriate Use of Drug Testing in Clinical Addiction Medicine document, which guides provider decisions about drug testing, as no universal standard exists today. It will allow providers, patients and their families, healthcare administrators, and payers determine clearly what is appropriate practice and what is considered outside the realm of appropriate practice in regard to drug testing in clinical addiction medicine. This webinar is primarily intended for addiction specialists and all providers utilizing drug testing in the context of the identification, diagnosis, treatment, and monitoring of patients with, or at risk for, addiction. It will also be useful for physicians and other providers concerned about the possibility of addiction in their patient population.
Louis E. Baxter, Sr.
MD, DFASAM
Dr. Louis E. Baxter, Sr., MD, DFASAM is a Past ASAM President and is the President &CEO of thr Professional Assistance Program of New Jersey, Inc.
Dr. Baxter is a certified in Addiction Medicine by the American Board of Addiction Medicine and currently serves on the Board of Directors. Dr. Baxter has served and chaired many government advisory committees and panels which include SAMHSA, NIDA, CSAT, NIAAA, and a Presidential Advisor through ONDCP since the Clinton Administration.
Dr. Baxter has served the State of New Jersey in various capacities serving on the Governor's Council for Drug and Alcohol Addiction, Medical Director for the Division of Addiction Services, and most recently as the Addiction Medicine Consultant for the Division of Mental Health and Addiction Services. He has held academic appointments as Assistant Clinical Professor of Medicine for former University Medicine & Dentistry and niw currently with Rutgers New Jersey Medical School in Newark, NJ. Dr. Baxter is serving as Co-Director if the Addiction Medicine Fellowship Program at Howard University Medical School and Hospital.
Upon completion of this activity, participants should be able to:
-Recognize the importance of the guidance needed around drug testing today
-Identify the fundamental components of drug testing in a clinical setting
-Summarize the document's recommendations and discuss how they should be used in practice
-Address common clinical questions around drug testing in a clinical setting-
Register
- Regular Member - Free!
- Retired - Free!
- Early Career Physician - Free!
- Resident - Free!
- Student - Free!
- Associate - Free!
- ASAM Staff - Free!
- Non-Member - Free!
- International Member - Free!
- Emeritus Member - Free!
- Provisional Member - Free!
- Fellow Member - Free!
- Honorary Member - Free!
- CRT Member - Free!
- More Information
-
Register
-
Contains 4 Component(s)
This activity has been designed to meet the educational needs of clinicians including, physicians, physician assistants, nurse practitioners, nurses, and dentists/oral maxillofacial surgeons, involved in the care of adolescent patients.
ASAM is part of a collaboration that made this course possible.
Educational Objectives
After completing this activity, the participant should be better able to:
Part 1
- Describe the prevalence of substance use and prescription drug misuse among adolescents
- Explain why adolescents are at high risk of developing a substance use disorder and how clinicians can help prevent it
- Demonstrate strategies to build trust with adolescent patients and ensure confidentiality when addressing substance use and prescription drug misuse
- Summarize ways to identify substance use and prescription drug misuse in adolescent patients, including determining their level of risk
Part 2
- Discuss strategies to address substance use and prescription drug misuse in adolescent patients based on their level of use
- Summarize when and how to follow up with adolescent patients who use substances or misuse prescription drugs
Physician Continuing Medical Education
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and the National Institute for Drug Abuse. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Credit Designation
This educational activity for 1.0 contact hour is provided by Postgraduate Institute for Medicine.
Accreditation Statement
Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
American Dental Association CERP Recognition
This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint sponsorship efforts between Postgraduate Institute for Medicine and the National Institute for Drug Abuse.
Postgraduate Institute for Medicine is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of the credit hours by boards of dentistry.
Postgraduate Institute for Medicine designates this activity for 1.0 continuing education credit.
Education Coalition
This activity was developed by an education Coalition of experts and medical professional organization representatives. The Coalition comprises the following organizations and experts:
Type of Reviewer: Organization/ Expert Consultant
Reviewer Name
California Academy of Family Physicians (CAFP)
Cynthia Kear, Senior Vice President
American Society of Addiction Medicine (ASAM)
Jennifer Butchart, Specialist, Professional Development
Penny S. Mills, MBA, Executive Vice President / CEO
Arlene C. Deverman, CAE, Chief Learning OfficerAmerican Osteopathic Association (AOA)
Stephanie Townsell, Public Health Project Manager
Marla Kushner, DO
American Association of Nurse Practitioners (AANP)
Anne Norman, DNP, APRN, FNP-BC, Associate Vice President of Education
American Academy of Pediatrics (AAP)
Renee Jarrett, Manager, Mental Health and Foster Care Initiatives Div of Developmental Pediatrics and Preventive Services
American Academy of Physician Assistants (AAPA)
Daniel Pace, Vice President, Education
Marie-Michele Leger, MPH, PA-C, Director, Clinical Education Sara Evans, PMP, Project Manager, Quality Improvement InitiativesAmerican Association of Oral and Maxillofacial Surgeons (AAOMS)
Vincent DiFabio, DDS
Consultant
Samantha Mattiucci, PharmD, CHCP, Director of Medical Education
Consultant
Jan Schultz, BSN, MSN, RN, CHCP, Director of Education Outcomes and Accreditation Services
Consultant
Dan Alford, MD, Associate Professor of Medicine, Assistant Dean and Program Director of the Addiction Medicine Residency program at Boston University School of Medicine
Consultant
Sharon Levy, Director, Adolescent Substance Abuse Program (ASAP)Assistant Professor in Pediatrics, Boston Children's Hospital
Consultant
Jeff Baxter, MD, Assistant Professor Department of Family Medicine and Community Health, University of Massachusetts Medical School
Consultant
Marc Fishman, MD
Consultant
Carol Havens, MD
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The Education Coalition members reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Marc Fishman, MD discloses the following: Consulting Fees: US World Meds; Contracted Research: Media Rez, US World Meds
Ownership Interest: Maryland Treatment Centers
The following Education Coalition members have nothing to disclose: Cynthia Kear, Jennifer Butchart, Penny Mills, Arlene Deverman, Stephanie Townsell, Marla Kushner, Anne Norman, Renee Jarrett, Daniel Pace, Marie-Michele Leger, Sara Evans, Vincent DiFabio, Jan Schultz, Dan Alford, Sharon Levy, Jeff Baxter, Marc Fishman, and Carol Havens
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
The following National Institute on Drug Abuse planners and managers, Elisabeth Davis; Carol Krause; Josie Anderson; Jack Stein, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months
The following JBS International, Inc. planners and managers, Candace Baker; Susan Hayashi; Laura Nolan; Bethel Arya; and Veronica Junghahn, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months
For Physicians, Registered Nurses and Dentists, please follow the instructions below:
PIM supports Green CME by offering your Request for Credit online. If you wish to receive acknowledgment for completing this activity, please follow the steps below:
- Go to CME University at: www.cmeuniversity.com and register or login
- Once logged in, click on “Find Post-test/Evaluation by Course” at the top of the page
- Type in 11118 (for Part1) or 12614 (for Part 2) in the box; hit enter
- Click on the activity title
- Complete the online posttest and evaluation and obtain your CME certificate to download and/or print for your files.
Upon completion of the online posttest and evaluation form, you will have immediate access to a certificate of attendance to print or save for your files. You can save your certificate by selecting the “Save” option on the print screen.
For any questions relating to the physician, nursing or dentist accreditation, please contact PIM via: inquiries@pimed.com
For Nurse Practitioners follow the instructions below:
- Visit the AANP’s Website (coming soon) to take the course for AANP credit.
For Physician Assistants follow the instructions below:
- Visit the AAPA’s Website to take the course for AAPA credit.
For Doctors of Osteopathic Medicine follow the instructions below:
Visit the AOA’s Website (coming soon) to take the course for AOA credit.
Internet activity
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
-
Register
- Regular Member - Free!
- Retired - Free!
- Early Career Physician - Free!
- Resident - Free!
- Student - Free!
- Associate - Free!
- ASAM Staff - Free!
- Non-Member - Free!
- International Member - Free!
- Emeritus Member - Free!
- Provisional Member - Free!
- Fellow Member - Free!
- Honorary Member - Free!
- CRT Member - Free!
- More Information
-
Contains 3 Component(s), Includes Credits
Component Credit Type State/Medical Type Available Credits Earned Credits CME Certificate Medical Physician - Online 1.00 0.00 CME Certificate Medical Non-Physician - Online 1.00 0.00 Nearly 20.5 million Americans suffer from a substance use disorder (SUD), yet only 1 in 10 people with a substance use disorder (SUD) receive treatment. This treatment gap leaves millions without the proper treatment, expanding the addiction medicine workforce is vital. During this webinar, we will discuss how physicians can become board-certified in Addiction Medicine under the new medical subspecialty.
The 60-minute webinar will provide insights into current addiction treatment gap and how physicians can close this gap by becoming board-certified in addiction medicine certified through the upcoming American Board of Preventive Medicine addiction medicine exam
This webinar is targeted toward clinicians, physicians, academicians and other addiction medicine professionals looking to learn more the addiction treatment gap and the new addiction medicine subspecialty under the American Board of Preventive Medicine (ABPM).
The purpose of the webinar is to emphasize the need to close the current treatment gap and increase the addiction medicine workforce. There will be a key focus on the new addiction medicine subspecialty and the pathways for certification. There will be a live question and answer session during the webinar to address any concerns and foster conversation around this monumental development in the field.
- Addiction medicine specialists
- Opioid treatment program providers
- DATA-waived provider
- Public health management services providers
Upon completion of this activity, participants will be able to:
- Demonstrate the importance of the need for an expanded workforce.
- Describe the different hurdles patients faces when seeking treatment for addiction treatment.
- Identify different demographics that are uniquely affected by the treatment gap.
- Diagram the different learning methods physicians can take to educate themselves in addiction medicine.
- Construct an outline of the different pathways physicians can take to become eligible to sit for the addiction medicine exam.
- Identify certain criteria physicians have to uphold in order to become an addiction specialist.
ACCME Accreditation Statement The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
AMA Credit Designation Statement: The American Society of Addiction Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASAM 2017-2018 CME Committee Disclosure Information:
Name
Nature of Relevant Financial Relationship
Commercial Interest
What was received?
For what role?
Catherine Friedman, MD, Chair
None
Adam J. Gordon, MD, MPH, FACP, DFASAM, CMRO
None
Noel Ilogu, MD, MRCP, DFASAM
None
Hebert L. Malinoff, MD, FACP, DFASAM
None
Edwin A. Salsitz, MD, DFASAM
None
John C. Tanner, DO, DABAM, DFASAM, CCFC, MRO
Indivior
BDSI
Honorarium
Honorarium
Speaker
Consultant/Speaker
April 7, 2017 – April 2018
-
Register
- Regular Member - Free!
- Retired - Free!
- Early Career Physician - Free!
- Resident - Free!
- Student - Free!
- Associate - Free!
- ASAM Staff - Free!
- Non-Member - Free!
- International Member - Free!
- Emeritus Member - Free!
- Provisional Member - Free!
- Fellow Member - Free!
- Honorary Member - Free!
- CRT Member - Free!
- More Information
Access Date | Quiz Result | Score | Actions |
---|